BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Acrux Limited To Start USA Trial Of Its Unique Testosterone Lotion For Men

  September 18, 2006

   · 

  1 min read
• Pharm Country

  Opexa Therapeutics CEO To Ring The NASDAQ Stock Market Closing Bell

  September 18, 2006

   · 

  1 min read
• Policy

  GlaxoSmithKline Seeks U.S. Approval For Tykerb(R) (Lapatinib Ditosylate) For The Treatment Of Advanced Breast Cancer

  September 18, 2006

   · 

  1 min read
• Business

  BIOIDENT Technologies To Deliver Optoelectronic Lab-On-A-Chip Solutions For Mobile Diagnostics And Analysis; Company Opens U.S. Headquarters In Silicon Valley; Appoints CEO And CTO

  September 18, 2006

   · 

  1 min read
• Business

  MIV Therapeutics Inc. Appoints Mid-America Heart Institute Director Dr. David Cohen To Scientific Advisory Board; Respected Interventional Cardiologist To Assist Commercialization Of MIVT Technologies For Safer Cardiovascular Stents

  September 18, 2006

   · 

  1 min read
• Business

  UTMB Galveston Opens Expanded GI Suite Equipped With Endoscopy And Imaging Equipment From PENTAX Medical Company

  September 18, 2006

   · 

  1 min read
• Business

  Gregory B. Lawless Appointed To Board Of Vyteris Holdings (Nevada), Inc.

  September 18, 2006

   · 

  1 min read
• Deals

  Integrated DNA Technologies Acquires Belgian Manufacturer RNA-TEC; Purchase Expands IDT’s Large-Scale RNA Synthesis Capabilities; Builds Presence In European Markets

  September 18, 2006

   · 

  2 min read
• Business

  High Throughput Genomics, Inc. Appoints William Radany CEO

  September 18, 2006

   · 

  3 min read
• Business

  Cell Therapeutics, Inc. Announces Worldwide License And Co-Development Agreement For Development And Commercialization Of XYOTAX(TM), Deal Worth Up To $285 Million

  September 18, 2006

   · 

  6 min read